PMID: 11607046Oct 19, 2001Paper

Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain

CNS Drug Reviews
J Knoll

Abstract

Hundreds of millions of people now die over the age of 80 years primarily due to twentieth century progress in hygiene, chemotherapy, and immunology. With a longer average lifespan, the need to improve quality of life during the latter decades is more compelling. "Aging--The Epidemic of the New Millenium," a recent international conference (Monte Carlo, June 17-18, 2000), showed with peculiar clarity that a safe and efficient drug strategy to slow the age-related decay of brain performance is still missing. This review summarizes the physiologic and pharmacologic arguments in favor of a peculiar lifelong prophylactic medication with reasonable chances to keep in check brain aging and decrease the precipitation of age-related neurological diseases.

References

Dec 1, 1978·British Journal of Clinical Pharmacology·G P ReynoldsG M Stern
Jan 1, 1978·Journal of Neural Transmission·J Knoll
Jan 1, 1978·Journal of Neural Transmission·M SandlerG M Stern
Mar 1, 1992·Italian Journal of Neurological Sciences·G FinaliG L Piccinin
Mar 1, 1992·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A AgnoliN Martucci
Feb 1, 1992·Neurology·V V MyllyläE H Heinonen
Dec 1, 1991·Clinical Neuropharmacology·G FinaliG L Piccinin
Jan 1, 1991·Acta Neurologica Scandinavica. Supplementum·H AllainH C Neukirch
Jan 1, 1991·Acta Neurologica Scandinavica. Supplementum·A J Lees
Jan 1, 1991·European Neurology·A MangoniS Smirne
Apr 1, 1990·Clinical Neuropharmacology·G L PiccininM Piccirilli
Jan 1, 1990·Life Sciences·N W MilgramG O Ivy
Aug 2, 1990·European Journal of Pharmacology·K T FinneganJ W Langston
Nov 16, 1989·The New England Journal of Medicine·UNKNOWN Parkinson Study Group
Jan 1, 1983·Modern Problems of Pharmacopsychiatry·J KnollJ Dallo
Jan 1, 1984·Journal of Neural Transmission·W BirkmayerJ Knoll
Jan 1, 1983·Acta Neurologica Scandinavica. Supplementum·J Knoll
Jan 1, 1995·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·J Knoll
Aug 1, 1994·Pharmacology & Toxicology·J Knoll
Nov 1, 1993·Journal of the American Geriatrics Society·W J BurkeN K Willcockson
Jan 21, 1993·The New England Journal of Medicine·UNKNOWN Parkinson Study Group
Nov 1, 1996·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·J R Archer, D E Harrison

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición
Christiane Carmem-Costa-do-NascimentoMaria José de-Carvalho-Costa
Journal of the American Academy of Dermatology
S A MyersJ A Bartlett
Journal of Hypertension
Panteleimon A Sarafidis, Peter M Nilsson
© 2021 Meta ULC. All rights reserved